Latterell Venture Partners

Latterell Venture Partners

Latterell Venture Partners

Follow us
Alexa global traffic share
Latest investments Show all
$18,400,000
Venture capital (Series B)
Viracta Therapeutics
$65,000,000
Venture capital (Series A)
Aptinyx Inc.
Team Size
1–10
Employees
Geographical Focus
Past year's investments

Latterell Venture Partners participated in fewer than 3 rounds over the past year

Latest rounds
  • Viracta Therapeutics: Venture capital (Series B) ($18.4M)
  • Aptinyx Inc.: Venture capital (Series A) ($65M)
  • Neuraltus Pharmaceuticals: Venture capital ($1.5M)